Announcement on Outline of the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
The briefing was held online, allowing for interaction between company representatives and investors, addressing key questions raised by attendees.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Nanjing Pharmaceutical Group Company Limited on 6ix
Later from Nanjing Pharmaceutical
- Announcement on Completion of Company Full Name and Registered Capital Change Registration and Filing of the "Articles of Association"
- Announcement on Change of Share Nature and Progress in Reserved Grant under 2025 Restricted Stock Incentive Plan
- Announcement on Government’s Expropriation of Certain Real Estate and Land of the Company’s Tier-II Subsidiary
- Announcement on Interest Payment for Corporate Convertible Bonds in 2025
- Announcement on Redemption of Some Temporarily Idle Raised Funds Used for Cash Management upon Expiration by the Company and Its Subsidiary
Follow Nanjing Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing Pharmaceutical